Literature DB >> 21402652

Post-stroke fatigue: a treatment protocol that is being evaluated.

A M E E Zedlitz1, L Fasotti, A C H Geurts.   

Abstract

PURPOSE: Post-stroke fatigue is a common and debilitating complaint, which has only recently received attention in clinical rehabilitation. Until now, no evidence-based treatments have been available for the condition. Therefore, a new treatment was designed to reduce post-stroke fatigue complaints: Cognitive and Graded Activity Training (COGRAT). RATIONALE: Following the premise that post-stroke fatigue is primarily caused by brain damage, the treatment aims to prevent fatigue and to manage existing fatigue symptoms. The purpose of the added graded activity programme is to reduce fatigue by changing cognitions and enhancing physical fitness. THEORY INTO PRACTICE: COGRAT consists of a cognitive treatment and graded activity programme in small groups over 12 weeks. In the cognitive treatment, patients receive education on post-stroke fatigue and register their activities and fatigue to gain insight into their daily agenda and fatigability. Patients are then taught several compensation strategies. Cognitive behavioural therapy is used to diminish anxiety, facilitate behavioural change and manage fatigue symptoms. The graded activity programme consists of walking on a treadmill, strength training and home work assignments. Maximum heart rate and strength are increased from 40% at the beginning of the training to a maximum of 70%. CONSIDERATIONS FOR FUTURE IMPROVEMENTS: COGRAT is currently being evaluated in outpatients with severe post-stroke fatigue in a multicentre randomized controlled trial. Preliminary data suggest both positive short- and long-term effects. Adaptations for other neurological patient groups suffering from fatigue are suggested.

Entities:  

Mesh:

Year:  2011        PMID: 21402652     DOI: 10.1177/0269215510391285

Source DB:  PubMed          Journal:  Clin Rehabil        ISSN: 0269-2155            Impact factor:   3.477


  9 in total

1.  A patient-centric goal in time to blood pressure control from drug therapy initiation.

Authors:  Song Hee Hong; Junling Wang; Sunghee Tak
Journal:  Clin Transl Sci       Date:  2013-01-14       Impact factor: 4.689

2.  Poststroke fatigue: who is at risk for an increase in fatigue?

Authors:  Hanna Maria van Eijsden; Ingrid Gerrie Lambert van de Port; Johanna Maria August Visser-Meily; Gert Kwakkel
Journal:  Stroke Res Treat       Date:  2011-10-19

3.  Targeting fatigue in stroke patients.

Authors:  Andrew W Barritt; David G Smithard
Journal:  ISRN Neurol       Date:  2011-11-30

4.  Impact of poststroke fatigue on health-related quality of life of nigerian stroke survivors.

Authors:  Grace Vincent-Onabajo; Abdulbaqi Adamu
Journal:  J Stroke       Date:  2014-09-30       Impact factor: 6.967

Review 5.  Fatigue in patients with low grade glioma: systematic evaluation of assessment and prevalence.

Authors:  Ellen M P van Coevorden-van Loon; Marijke B Coomans; Majanka H Heijenbrok-Kal; Gerard M Ribbers; Martin J van den Bent
Journal:  J Neurooncol       Date:  2017-05-24       Impact factor: 4.130

6.  Automatic Detection of Compensation During Robotic Stroke Rehabilitation Therapy.

Authors:  Ying Xuan Zhi; Michelle Lukasik; Michael H Li; Elham Dolatabadi; Rosalie H Wang; Babak Taati
Journal:  IEEE J Transl Eng Health Med       Date:  2017-12-15       Impact factor: 3.316

7.  Poststroke Fatigue Is Related to Motor and Cognitive Performance: A Secondary Analysis.

Authors:  Hui-Ting Goh; Jill C Stewart
Journal:  J Neurol Phys Ther       Date:  2019-10       Impact factor: 3.649

8.  An increase in the cerebral infarction area during fatigue is mediated by il-6 through an induction of fibrinogen synthesis.

Authors:  Hong Lei; Jian Xu; Li-Juan Cheng; Qi Guo; An-Mei Deng; Yong-Shen Li
Journal:  Clinics (Sao Paulo)       Date:  2014-06       Impact factor: 2.365

9.  Cognitive rehabilitation and mindfulness in multiple sclerosis (REMIND-MS): a study protocol for a randomised controlled trial.

Authors:  Ilse M Nauta; Anne E M Speckens; Roy P C Kessels; Jeroen J G Geurts; Vincent de Groot; Bernard M J Uitdehaag; Luciano Fasotti; Brigit A de Jong
Journal:  BMC Neurol       Date:  2017-11-21       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.